載入...

Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial

BACKGROUND: The approval of extended release injectable naltrexone (XR-NTX; Vivitrol®) has introduced a new option for treating opioid addiction, but studies are needed to identify its place within the spectrum of available therapies. The absence of physiological opioid dependence is a necessary and...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Mannelli, Paolo, Wu, Li-Tzy, Peindl, Kathleen S., Swartz, Marvin S., Woody, George E.
格式: Artigo
語言:Inglês
出版: 2014
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4017322/
https://ncbi.nlm.nih.gov/pubmed/24602363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2014.02.002
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!